The effect of risk factors on surgical and oncological results in high-risk prostate cancer: A multicentre study of the urooncology society, Turkey

被引:1
|
作者
Izol, Volkan [1 ]
Akdogan, Nebil [1 ]
Ozen, Haluk [2 ]
Akdogan, Bulent [2 ]
Kural, Ali Riza [3 ]
Tuna, Mustafa Bilal [3 ]
Sozen, Sinan [4 ]
Turkeri, Levent [5 ]
Tansug, Mustafa Zuhtu [1 ]
机构
[1] Cukurova Univ, Fac Med, Dept Urol, TR-01330 Adana, Turkey
[2] Hacettepe Univ, Fac Med, Dept Urol, Ankara, Turkey
[3] Acibadem Univ, Acibadem Maslak Hosp, Dept Urol, Istanbul, Turkey
[4] Gazi Univ, Fac Med, Dept Urol, Ankara, Turkey
[5] Acibadem Univ, Altunizade Hosp, Dept Urol, Istanbul, Turkey
关键词
RADICAL PROSTATECTOMY; SURVIVAL; MORTALITY; THERAPY; OUTCOMES; IMPACT; MEN;
D O I
10.1111/ijcp.14281
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose To evaluate the effect of risk factors and selected surgical methods on operative and oncological results of patients undergoing radical prostatectomy (RP) with high-risk prostate cancer (HRPC). Methods Retrospective analysis of patients who underwent RP for HRPC from 13 urology centres between 1990 and 2019 was performed. Groups were created according to the risk factors of D'Amico classification. Patients with one risk factor were included in group 1 where group 2 consisted of patients with two or three risk factors. Results A total of 1519 patients were included in this study and 1073 (70.6%) patients were assigned to group 1 and 446 (29.4%) patients to group 2. Overall (biochemical and/or clinical and/or radiological) progression rate was 12.4% in group 1 and 26.5% in group 2 (P = .001). Surgical procedure was open RP in 844 (55.6%) patients and minimally invasive RP in 675 (44.4%) patients (laparoscopic and robot-assisted RP in 230 (15.1%) and 445 (29.3%) patients, respectively). Progression rates were similar in different types of operations (P = .22). Progression rate was not significantly different in patients who either underwent pelvic lymph node dissection (PLND) or not in each respective group. Conclusion RP alone is an effective treatment in the majority of patients with HRPC and PLND did not affect the progression rates after RP. According to the number of pre-operative high-risk features, as the number of risk factors increases, there is a need for additional treatment.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] The high-risk prostate cancer patient
    Hussain, M
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2003, 21 (03) : 211 - 211
  • [32] Radiotherapy for high-risk prostate cancer
    Jahan J. Mohiuddin
    Brock R. Baker
    Ronald C. Chen
    Nature Reviews Urology, 2015, 12 : 145 - 154
  • [33] The epidemiology of high-risk prostate cancer
    Punnen, Sanoj
    Cooperberg, Matthew R.
    CURRENT OPINION IN UROLOGY, 2013, 23 (04) : 331 - 336
  • [34] Radiotherapy for high-risk prostate cancer
    Mohiuddin, Jahan J.
    Baker, Brock R.
    Chen, Ronald C.
    NATURE REVIEWS UROLOGY, 2015, 12 (03) : 145 - 154
  • [35] Surgery for high-risk prostate cancer
    Eden, Christopher
    TRENDS IN UROLOGY & MENS HEALTH, 2014, 5 (01) : 19 - 22
  • [36] Novel Prognostic Index of High-Risk Prostate Cancer Using Simple Summation of Very High-Risk Factors
    Yamazaki, Hideya
    Suzuki, Gen
    Masui, Koji
    Aibe, Norihiro
    Shimizu, Daisuke
    Kimoto, Takuya
    Yamada, Kei
    Shiraishi, Takumi
    Fujihara, Atsuko
    Okihara, Koji
    Yoshida, Ken
    Nakamura, Satoaki
    Okabe, Haruumi
    CANCERS, 2021, 13 (14)
  • [37] Impact of "Time-From-Biopsy-to-Prostatectomy" on Adverse Oncological Results in Patients With Intermediate and High-Risk Prostate Cancer
    Engl, Tobias
    Mandel, Philipp
    Hoeh, Benedikt
    Preisser, Felix
    Wenzel, Mike
    Humke, Clara
    Welte, Maria
    Koellermann, Jens
    Wild, Peter
    Deuker, Marina
    Kluth, Luis A.
    Roos, Frederik C.
    Chun, Felix K. H.
    Becker, Andreas
    FRONTIERS IN SURGERY, 2020, 7
  • [38] Surgical treatment of patients with high-risk prostate cancer: long-term outcomes and prognostic factors
    Alekseev, B. Ya
    Krasheninnikov, A. A.
    Nyushko, K. M.
    Vorobyev, N. V.
    Kaprin, A. D.
    ONKOUROLOGIYA, 2020, 16 (04): : 99 - 111
  • [39] Surgery for high-risk prostate cancer and metastatic prostate cancer
    Safir, Ilan J.
    Lian, Fei
    Alemozaffar, Mehrdad
    Master, Viraj A.
    CURRENT PROBLEMS IN CANCER, 2015, 39 (01) : 33 - 40
  • [40] High-risk prostate cancer: How high is high?
    Sandler, HM
    CANCER JOURNAL, 2002, 8 (04): : 301 - 302